Prolactinoma
NEJM 349:2035-2041, Schlechte,J.A., 2003
Withdrawal of Long-Term Cabergoline Therapy for Tumoral and Nontumoral Hyperprolactinemia
NEJM 349:2023-2033, Colao,A.,et al, 2003
Long-term Treatment of Acromegaly With Pegvisomant, a Growth Hormone Receptor Antagonist
Lancet 358:1754-1759,1743, van der Lely,A.J.,et al, 2001
Treatment of Acromegaly With the Growth Hormone-Receptor Antagonist Pegvisomant
NEJM 342:1171-1177,1210, Trainer,P.J.,et al, 2000
Pituitary Surgery for Acromegaly, Should be Done by Specialists
BMJ 319:588-589, Clayton,R.N.,et al, 1999
Management of Pituitary Tumors
Ann Int Med 129:472-483, Shimon,I.&Melmed,S., 1998
The Long-Term Outcome of Pituitary Irradiation after Unsuccessful Transsphenoidal Surgery in Cushing's Disease
NEJM 336:172-177, 2151997., Estrada,J.,et al, 1997
Long-Term Octreotide Therapy in Growth Hormone-Secreting Pituitary Adenomas:Evaluation with Serial MR
AJNR 18:765-772, Lundin,P.,et al, 1997
Arterial Injuries in Transsphenoidal Surgery for Pituitary Adenoma:The Role of Angiography and Endovascular Treatment
ANJR 18:655-665, Raymond,J.,et al, 1997
Octreotide
NEJM 334:246-254, Lamberts,S.W.J.,et al, 1996
The Natural History of the Pituitary Incidentaloma
Arch Int Med 155:181-183, Donovan,L.E.&Corenblum,B., 1995
Diagnosis and Management of Pituitary Tumours
BMJ 308:1087-1091, Levy,A.&Lightman,S.L., 1994
Ten Year Follow Up of Microprolactinoma Treated by Transsphenoidal Surgery
BMJ 309:1409-1410, Thomson,J.A.,et al, 1994
Octreotide Therapy for Thyroid-Stimulation Hormone-Secreting Pituitary Adenomas, A Follow-up of 52 Patients
Ann Int Med 119:236-240, Chanson,P.,et al, 1993
Relapse of Hyperprolactinemia Revisited
NEJM 329:1357, Serri,O.,et al, 1993
Prolactin-Secreting Macroadenomas in Adolescents, Response to Bromocriptine Therapy
Am J Dis Child 147:1057-1061, Tyson,D.,et al, 1993
Acromegaly:Treatment After 100 Years
BMJ 307:1505-1506, Wass,J.A.H., 1993
Octreotide Treatment of Acromegaly, A Randomized, Multicenter Study
Ann Int Med 117:711-718, Ezzat,S.,et al, 1992
Diagnosis and Management of Hormone-Secreting Pituitary Adenomas
NEJM 324:822-831, Klibanski,A.&Zervas,N.T., 1991
Long-term Treatment of 189 Acromegalic Patients with the Somatostatin Analog Octreotide
Arch Int Med 151:1573-1578, Vance,M.L.&Harris,A.G., 1991
Treatment of Prolactin-Secreting Pituitary Macroadenomas with the Long-Acting Non-Ergot Dopamine Agonist CV 205-502
Ann Int Med 112:668-673, Vance,M.L.,et al, 1990
The'Incidentaloma'of the Pituitary Gland is Neurosurgery Required
JAMA 263:2772-2776, Reincke,M.,et al, 1990
The Pituitary"Incidentaloma"
Ann Int Med 112:925-931, Molitch,M.E.&Russell,E.J., 1990
Hyperprolactinaemia, Common and Treatable
BMJ 297:701-702, Hartog,M.&Hull,M.G.R., 1988
Response of Thyrotropin-Secreting Pituitary Adenomas to a Long-Acting Somatostatin Analogue
NEJM 317:12-17, Comi,R.J.,et al, 1987
Visual Improvement with SMS 201-995 in a Patient with a Thyrotropin-Secreting Pituitary Adenoma
NEJM 317:53-54, Guillaussea,P.J.,et al, 1987
Effective & Lasting Growth-Hormone Suppres in Active Acromegaly with Oral Admin of Somatostatin Analogue SMS 201-995
Lancet 2:774-778, Williams,G.,et al, 1986
Prolactinomas
Editorial, BMJ 290:182-1841985., Grossman,A.,et al, 1985
Long-Term Treatment of Acromegaly with the Somatostatin Analogue SMS 201-995
NEJM 313:1576-1580, 1604-16051985., Lamberts,S.W.J.,et al, 1985
Bromocriptine Reduces Pituitary Tumor Size & Hyper-secretion
JAMA 247:311-316, Spark,R.F.,et al, 1982
Bromocriptine in Management of Large Pituitary Tumours
BMJ 284:1908-1911, Wass,J.A.H.,et al, 1982
Reduction in Size of a Pituitary Tumor by Bromocriptine Therapy
NEJM 300:291-293, McGregor,A.M.,et al, 1979
Effect of Bromocriptine on Pituitary Tumor Size
BMJ 2:700-703, McGregor,A.M.,et al, 1979